Sustainability & Climate

A Dubai hospital pioneers a one-time gene therapy for an adult with SMA, offering new hope to a patient population previously left with limited options.

A new ultra-short-acting drug for cardiac emergencies is now in US hospitals, offering doctors faster control and broader use across all age groups.

A new partnership aims to equip independent advisors with elite family office capabilities, signaling a major shift in ultra-high-net-worth wealth management.

An aerospace engineer returned to her family farm, transforming it into an organic powerhouse against all odds with the help of a key partner, Sweetgreen.

The cold-pressed juice innovator is shaking up the RTD tea market with a new functional line, signaling a major shift in consumer beverage trends.

Swiss innovator KA-EX launches the first stable ready-to-drink creatine, using patented tech to unlock the supplement's full potential for a new era.

A landmark study shows a novel device can safely treat severe artery blockages below the ankle, offering new hope for patients at risk of amputation.

Backed by $37M and Hims & Hers co-founder Jack Abraham, Golden Child is challenging the fresh pet food market with a new science-backed food system.

A new AI video solution from V4b.AI promises to solve generative AI's accuracy problem, offering brands a scalable, shoot-free alternative for content.

Vensica Medical gets FDA clearance for a Phase 2 study of its ultrasound device that delivers botulinum toxin without needles for overactive bladder.

As GPS jamming becomes a critical threat, Northrop Grumman's new EGI-M system, powered by Green Hills software, ensures US jets stay on target.

The firm's unique chip design, integrating lasers on silicon, aims to solve the data bottleneck crippling AI and secures major deep tech investor backing.

Promising physician access in seconds, CirrusMD's new model, backed by Quantum Health, tackles the care crisis. But can it overcome virtual care's hurdles?

Neurogene bets on a direct-to-brain delivery method for its Rett syndrome gene therapy, arguing the established surgical technique offers superior results.

With the hire of Nike's Nik Rupp, Funko signals a major push into digital realms, aiming to fuse its physical collectibles with new virtual experiences.

A Toronto cycling club marks its 15th anniversary with an ambitious $1.5M goal, pushing its total fundraising for Hennick Humber Hospital past $7M.

Kiniksa raises its 2026 ARCALYST forecast after a blowout quarter, using its financial strength to advance a pipeline aimed at redefining pericarditis care.

ThreatDown, the business-focused unit from Malwarebytes, has radically transformed its sales model, betting its future on a partner-first strategy.

A new report reveals 80% of security pros fear AI will cut jobs, while AI-powered malware and ransomware attacks continue to surge globally.

A new four-ingredient liposome formula shows breakthrough results in skin health, signaling a major shift for the cosmetic and nutraceutical markets.